Lv1
50 积分 2024-12-10 加入
Exploring Clearance Pathways for GalNAc–siRNAs: Insights into Intracellular Kinetics and Therapeutic Implications
1个月前
已完结
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic
1个月前
已完结
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
1个月前
已完结
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
1个月前
已完结
Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody–Drug Conjugate
2个月前
已完结
Objective criteria for statistical assessments of cross validation of bioanalytical methods
4个月前
已完结
Mitigation of pre-existing immunogenicity in ADA method development
4个月前
已完结
Addressing soluble target interference in the development of a functional assay for the detection of neutralizing antibodies against a BCMA-CD3 bispecific antibody
5个月前
已完结
Tebentafusp: First Approval
5个月前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
6个月前
已完结
皖公网安备34019202002308
